Nabumetone is a non steroidal anti-inflammatory drug with good analgesic and anti-rheumatic properties. Various methods for analysis of the same are available but are time consuming and expensive. Two simple, precise, accurate and economical UV spectrophotometric methods have been developed and validated for the routine estimation of Nabumetone in bulk drug and pharmaceutical preparations. The drug shows maximum absorption at 229.0 nm and obeyed Beer-Lambert's law in the concentration range of 1-5μg/ml. The same spectrum was derivatised into second order derivative the amplitude of trough at 230.0 nm and creast 236.8nm for D 2 were measured. In D 2 method the drug showed linearity in the concentration range of 1-5 μg/ml. The linear regression equations were calculated to be y=0. 
Introduction
Nabumetone, 4-(6-methoxy-2-naphthyl)-butan-2-one, is a non-steroidal anti-inflammatory drug (NSAID) of naphtylalkanone class. The drug has proved to be effective in the treatment of rheumatoid arthritis, osteoarthritis and acute soft tissue injuries 3, 4 . Nabumetone is a prodrug which undergoes extensive first pass metabolism to 6-methoxy-2-naphthylacetic acid (6-MNA), the major circulating metabolite. 6-MNA is largely responsible for the therapeutic efficacy of nabumetone. It decreases prostaglandin synthesis via inhibition of cyclooxygenase, an enzyme involved in the arachidonic acid conversion pathway 1 The experiments were repeated three times in a day to determine intraday precision and on three different days to determine interday precision. The results of the same are presented in Table No. 3.
Selectivity
The selectivity of the methods was checked by monitoring a standard solution of Nabumetone in presence of excipients at the same concentration level as used in tablet using the method described in the procedure for calibration curve in pharmaceutical tablets.
Limit of Detection (LOD) and Limit of Quantitation (LOQ)
The LOD and LOQ of Nabumetone by proposed methods were determined using calibration standards. LOD and LOQ were calculated as 3.3/S and 10 /S, respectively, where S is the slope of the calibration curve and  is the standard deviation of response. The results of the same are shown in Table  No. 3.
Results and Discussion
The proposed methods are simple, rapid and precise and do not suffer from any interference due to excipients of tablet. Various optical characteristics are shown in the ) for D 2 were found to be 0.9931 and 0.9987 respectively. The methods were validated in terms of accuracy, precision, repeatability and the results are recorded in Table No .2 and 3.The accuracy of the method was determined by performing recovery studies by standard addition of method in which preanalyzed samples were taken and standard drug was added at three different levels. Values of recovery greater than 98.0% indicate that proposed method is accurate for the analysis of the drug. The precision of the proposed method was estimated in terms of interday precision and intraday precision wherein the method was repeated on three different days and repeated for three different time periods in the same day respectively. The results shown in Table No. 3. SD less than 2% at each level clearly indicate that the proposed method is precise enough for the analysis of the drug. The selectivity of the method was checked by monitoring a standard solution of nabumetone in presence of excipients at the same concentration level as used in tablet using the method described in the procedure for calibration curve in pharmaceutical tablets. The excipients did not show any effect on the estimation of nabumetone. Hence, the determination of nabumetone in the tablet is considered to be free from interference due to the excipients. Rigorous analysis of the results indicates that the presence of excipients in tablet formulation did not interference with the final determination of the active component. This reveals that the potential utility of this method for the routine analysis of nabumetone in pharmaceutical preparations.
Conclusion
Two new, simple precise, accurate and selective spectrophotometric methods were developed for the analysis of Nabumetone in bulk and in pharmaceutical formulation. The D 0 method is useful for tablet formulations where there is no interference of excipients in the absorbance of Nabumetone and method D 2 can be utilized for formulations containing any interfering excipients. The developed methods were also validated and from the statistical data, it was found that methods were accurate, precise, reproducible and can be successfully applied to the pharmaceutical formulations without interference of excipients. 
